Related Experiment Video
Updated: Aug 18, 2026
Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
Published on: November 30, 2012
[Pharmacologic brain protection: specific agents]
1Department of Anesthesiology, SUNY Health Science Center at Brooklyn, USA.
Abstract:
Dysfunctional sodium influx is the first step in the ischaemic cascade. It has been recently demonstrated that reducing ionic flux through voltagegated Na channels shortens the NMDA receptor activity of cultured hippocampal slices in which oxidative phosphorylation and glycolysis have been blocked. The implication of this finding is that blocking initial events in the ischaemic cascade, events which do not directly cause neuronal damage, will reduce the damage done by downstream events. It also seems intuitively reasonable to suppose that truncating initial steps of the ischaemic cascade, as distinct from blocking glutamate receptors and scavening free radicals, will reduce the probability of interfering with endogenous mechanisms of repair. Clinically useful, substantive, prophylactic, pharmacological cerebral protection will come from drugs that work upstream. And for pharmacological protection that can only be initiated subsequent to an ischaemic event, the more we learn about endogenous repair, or genetic pharmacology, the closer we will come to maximizing the benefits and minimizing the costs of downstream intervention.
Insights
Targeting early sodium influx in the ischaemic cascade, before direct neuronal damage occurs, can reduce overall brain injury. Intervening upstream offers a promising strategy for neuroprotection with fewer side effects.
Area of Science:
- Neuroscience
- Cellular Biology
- Biochemistry
Context:
- Ischaemic cascade initiates neuronal damage through a series of events.
- Dysfunctional sodium influx is identified as the primary step in this cascade.
- Previous research focused on downstream events like glutamate receptor activity and free radical scavenging.
Purpose:
- To investigate the neuroprotective potential of targeting early events in the ischaemic cascade.
- To evaluate the effect of reducing ionic flux through voltage-gated sodium channels on neuronal activity.
- To explore upstream pharmacological interventions for cerebral protection.
Summary:
- Blocking early ionic flux through voltage-gated sodium channels reduces NMDA receptor activity in hippocampal slices.
- This intervention occurs before direct neuronal damage, suggesting a prophylactic benefit.
- Targeting upstream events may minimize interference with endogenous repair mechanisms.
Impact:
- Suggests that prophylactic pharmacological interventions targeting initial ischaemic events can reduce brain damage.
- Highlights the potential of upstream drug targets for cerebral protection.
- Emphasizes the importance of understanding endogenous repair for optimizing downstream interventions.
More Related Videos
09:48Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
10:13Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Related Concept Videos
00:49The Blood-brain Barrier
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
01:22Alzheimer's Disease: Treatment
01:14Antiepileptic Drugs: Glutamate Antagonists
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:23Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...